Gan To Kagaku Ryoho
November 2024
Aim: This study evaluated changes in carcinoembryonic antigen(CEA)values obtained using measurement methods.
Patients And Methods: For this analysis, 163 patients with colorectal cancer who underwent new CEA measurements between January and March 2023 were included. Centaur XP or XPT was used as the assay device and ADVIA Centaur CEA was used as the reagent until December 2022(old assay method).
A 55-year-old woman receiving treatment for anorexia nervosa presented with abdominal pain and right thigh pain. Her body mass index was 12.9 kg/m .
View Article and Find Full Text PDF